(Total Views: 120)
Posted On: 07/17/2023 8:50:48 AM
Post# of 145184

$CMPS News Article - COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology https://marketwirenews.com/news-releases/comp...36233.html


My Twitter: WhyteStocks